Compare Li Auto Inc (LI) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Li Auto Inc vs McKesson Corporation — how do they compare? Li Auto Inc trades at $12.62 (market cap $12.28B), while McKesson Corporation trades at $898 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 8.6× Li Auto Inc's market cap, and McKesson Corporation pays a 0.42% dividend while Li Auto Inc pays none. Which is the better fit depends on your goals.
| LI | MCK | |
|---|---|---|
Market Cap | $12.28B | $105.14B |
Sector | Consumer Cyclical | Health |
52-Week High | $26.69 | $995.69 |
52-Week Low | $11.74 | $659.01 |
Enterprise Value | $1.11B | $111.67B |
Dividend Yield | — | 0.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Li Auto Inc
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 90,000 EVs in 2021, accounting for about 2.7% of China's passenger new energy vehicle market. Beyond Li One, the company will expand its product line, including both BEVs and PHEVs, to target a broader consumer base.
Read more on LI →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
